These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 33051897)

  • 1. Radiographic Improvement of Larval Cysts in Neurocysticercosis.
    Landzberg DR; Dhir A; Jillella DV
    Ann Neurol; 2021 Feb; 89(2):416-417. PubMed ID: 33051897
    [No Abstract]   [Full Text] [Related]  

  • 2. Anticysticercal treatment and seizures in neurocysticercosis.
    Singh G; Sander JW
    Lancet Neurol; 2004 Apr; 3(4):207-8. PubMed ID: 15039032
    [No Abstract]   [Full Text] [Related]  

  • 3. Combination therapy with albendazole and praziquantel versus albendazole alone in children with seizures and single lesion neurocysticercosis: a randomized, placebo-controlled double blind trial.
    Kaur S; Singhi P; Singhi S; Khandelwal N
    Pediatr Infect Dis J; 2009 May; 28(5):403-6. PubMed ID: 19325515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Routine drug and food interactions during antihelminthic treatment of neurocysticercosis: a reason for the variable efficacy of albendazole and praziquantel?
    Romo ML; Carpio A; Kelvin EA
    J Clin Pharmacol; 2014 Apr; 54(4):361-7. PubMed ID: 24443292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis: Cysticidal drugs for neurocysticercosis: albendazole and praziquantel.
    Del Brutto OH; Roos KL; Coffey CS; García HH
    Ann Intern Med; 2006 Jul; 145(1):43-51. PubMed ID: 16818928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Combination Therapy of Albendazole and Praziquantel vs Albendazole Monotherapy in Children With Persistent Neurocysticercosis: A Randomized Controlled Trial.
    Singh K; Saini AG; Khandelwal N; Singhi P
    J Child Neurol; 2022 Apr; 37(5):366-372. PubMed ID: 35213246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of albendazole and short-course dexamethasone treatment in children with 1 or 2 ring-enhancing lesions of neurocysticercosis: a randomized controlled trial.
    Kalra V; Dua T; Kumar V
    J Pediatr; 2003 Jul; 143(1):111-4. PubMed ID: 12915835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lumbosacral Radiculopathy as the Clinical Presentation of Neurocysticercosis.
    Pérez-Jacoiste Asín MA; Calleja-Castaño P; Hilario A
    Am J Trop Med Hyg; 2020 Jun; 102(6):1166-1167. PubMed ID: 32519649
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial.
    Garcia HH; Gonzales I; Lescano AG; Bustos JA; Zimic M; Escalante D; Saavedra H; Gavidia M; Rodriguez L; Najar E; Umeres H; Pretell EJ;
    Lancet Infect Dis; 2014 Aug; 14(8):687-695. PubMed ID: 24999157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Be careful while using albendazole/praziquantel in neurocysticercosis.
    Garg RK; Uniyal R; Malhotra HS
    Neurol India; 2017; 65(4):924-926. PubMed ID: 28681797
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical analysis of 52 cases of neurocysticercosis.
    Chaoshuang L; Zhixin Z; Xiaohong W; Zhanlian H; Zhiliang G
    Trop Doct; 2008 Jul; 38(3):192-4. PubMed ID: 18628562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Difficult to control epilepsy in young female: a common problem in a low resource setting.
    Segamwenge IL; Kioko NP
    Pan Afr Med J; 2014; 18():212. PubMed ID: 25419338
    [No Abstract]   [Full Text] [Related]  

  • 13. Intramedullary Neurocysticercosis Successfully Treated with Medical Therapy.
    Yadav K; Garg D; Kaushik JS; Vaswani ND; Dubey R; Agarwal S
    Indian J Pediatr; 2017 Sep; 84(9):725-726. PubMed ID: 28466406
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical spectrum of 500 children with neurocysticercosis and response to albendazole therapy.
    Singhi P; Ray M; Singhi S; Khandelwal N
    J Child Neurol; 2000 Apr; 15(4):207-13. PubMed ID: 10805184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subarachnoidal Neurocysticercosis non-responsive to cysticidal drugs: a case series.
    Cárdenas G; Carrillo-Mezo R; Jung H; Sciutto E; Hernandez JL; Fleury A
    BMC Neurol; 2010 Mar; 10():16. PubMed ID: 20202200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of neurocysticercosis.
    The Lancet Infectious Diseases
    Lancet Infect Dis; 2014 Aug; 14(8):657. PubMed ID: 25056011
    [No Abstract]   [Full Text] [Related]  

  • 17. Medical management of neurocysticercosis.
    Takayanagui OM; Odashima NS; Bonato PS; Lima JE; Lanchote VL
    Expert Opin Pharmacother; 2011 Dec; 12(18):2845-56. PubMed ID: 22082143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined antiparasitic treatment for neurocysticercosis.
    Mahamat A; Abboud P; Demar M; JeanBourquin D; Djossou F
    Lancet Infect Dis; 2015 Mar; 15(3):264-5. PubMed ID: 25749224
    [No Abstract]   [Full Text] [Related]  

  • 19. Combined antiparasitic treatment for neurocysticercosis.
    Wang W
    Lancet Infect Dis; 2015 Mar; 15(3):265-6. PubMed ID: 25749225
    [No Abstract]   [Full Text] [Related]  

  • 20. Combined antiparasitic treatment for neurocysticercosis.
    Carpio A; Romo ML
    Lancet Infect Dis; 2015 Mar; 15(3):265. PubMed ID: 25749226
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.